Monday, June 5, 2023
Home Tags Takeda

Tag: Takeda

Takeda to Present Oncology Portfolio and Pipeline Data at the 2023 ASCO Annual Meeting and EHA Congress
Featured

Takeda to Present Oncology Portfolio and Pipeline Data at the 2023...

BFN's Desk - 0
Takeda and HUTCHMED Announce New Drug Application NDA for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Featured

Takeda and HUTCHMED Announce New Drug Application NDA for Fruquintinib for...

BFN's Desk - 0
Takeda Delivers Strong Revenue and Profit Growth in FY2022 Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
Uncategorized

Takeda Delivers Strong Revenue and Profit Growth in FY2022 Updated Capital...

BFN's Desk - 0
Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
Featured

Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for...

BFN's Desk - 0
Bourns Inc, Hindustan Times, Obayashi Road Corp and Takeda Pharma are the winners of 2022 Findability Sciences’ Enterprise AI Awards
Featured

Bourns Inc, Hindustan Times, Obayashi Road Corp and Takeda Pharma are...

BFN's Desk - 0
Insurance-Tips

Takeda Korea’s Kynteles SC wins insurance benefit < Pharma < 기사본문

BFN's Desk - 0
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
Featured

Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk...

BFN's Desk - 0
Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States
Featured

Takeda Signs Virtual Power Purchase Agreement with Enel North America to...

BFN's Desk - 0
Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies
Featured

Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of...

BFN's Desk - 0
Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program to Strengthen Health Systems in Low- and Middle-Income Countries
Featured

Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program...

BFN's Desk - 0
businessfortnight
Businessfortnight is your news, automobile, aviation, business, market, healthcare, entertainment, banking, insurance website. We provide you with the latest breaking news and videos straight from various industries.
Contact us: editorbusinessfortnight [@] gmail.com

POPULAR POSTS

POPULAR CATEGORY

© All Copyright Reserved